Caption Management’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 997 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 1065 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 983 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 840 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 800 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 883 |
|
|
2023
Q4 | – | Sell |
-33,300
| Closed | -$278K | – | 856 |
|
|
2023
Q3 | $278K | Buy |
+33,300
| New | +$278K | ﹤0.01% | 278 |
|
|
2023
Q2 | – | Sell |
-34,629
| Closed | -$521K | – | 740 |
|
|
2023
Q1 | $521K | Buy |
+34,629
| New | +$521K | 0.01% | 174 |
|
|
2022
Q4 | – | Sell |
-425,000
| Closed | -$2.52M | – | 835 |
|
|
2022
Q3 | $2.52M | Buy |
425,000
+355,000
| +507% | +$2.1M | 0.03% | 42 |
|
|
2022
Q2 | $298K | Buy |
+70,000
| New | +$298K | ﹤0.01% | 320 |
|
|
2022
Q1 | – | Sell |
-639,900
| Closed | -$12.2M | – | 966 |
|
|
2021
Q4 | $12.2M | Buy |
639,900
+594,900
| +1,322% | +$11.3M | 0.14% | 25 |
|
|
2021
Q3 | $1.5M | Buy |
45,000
+39,750
| +757% | +$1.32M | 0.02% | 206 |
|
|
2021
Q2 | $204K | Buy |
+5,250
| New | +$204K | ﹤0.01% | 341 |
|
|
2020
Q3 | – | Sell |
-8,800
| Closed | -$172K | – | 623 |
|
|
2020
Q2 | $172K | Sell |
8,800
-36,200
| -80% | -$708K | 0.01% | 231 |
|
|
2020
Q1 | $443K | Buy |
+45,000
| New | +$443K | 0.03% | 156 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 520 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 473 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 435 |
|
|
2018
Q4 | – | Sell |
-20,900
| Closed | -$117K | – | 349 |
|
|
2018
Q3 | $117K | Buy |
+20,900
| New | +$117K | 0.01% | 180 |
|